Synthesis and evaluation of novel 8,5-fused bicyclic peptidomimetic compounds as interleukin-1beta converting enzyme (ICE) inhibitors.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2006-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BMC.2006.07.056PMID 16908171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytokines as Therapeutic Targets for Osteoarthritis

  2012cited by this paper
• Evolution of a total synthesis of (-)-kendomycin exploiting a Petasis-Ferrier rearrangement/ring-closing olefin metathesis strategy.

  2006cited by this paper
• Synthesis and evaluation of novel 8,6-fused bicyclic peptidomimetic compounds as interleukin-1beta converting enzyme inhibitors.

  2005cited by this paper
• Synthesis and evaluation of tricyclic pyrrolopyrimidinones as dipeptide mimetics: inhibition of interleukin-1beta-converting enzyme.

  2005cited by this paper
• Synthesis and evaluation of novel 8,6-fused bicyclic peptidomimetic compounds as interleukin-1β converting enzyme inhibitors

  2005cited by this paper
• Synthesis and evaluation of tricyclic pyrrolopyrimidinones as dipeptide mimetics: Inhibition of interleukin-1β-converting enzyme

  2005cited by this paper
• Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis.

  2003cited by this paper
• Synthesis of cyclic proline-containing peptides via ring-closing metathesis.

  2003cited by this paper
• Anticytokine therapy for osteoarthritis

  2001cited by this paper
• Caspases: recent advances in small molecule inhibitors

  2001cited by this paper
• Progress toward the total synthesis of ingenol: construction of the complete carbocyclic skeleton.

  2001cited by this paper
• Caspases as targets for anti-inflammatory and anti-apoptotic drug discovery.

  2000cited by this paper
• Synthetic studies of ingenol: synthesis of in,out-tricyclo[7.4.1.01,5]tetradecan-14-one

  2000cited by this paper
• The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity.

  2000cited by this paper
• Synthesis of Novel Unsaturated Bicyclic Lactams by Ring-Closing Metathesis

  1999cited by this paper
• Pyridazinodiazepines as a high-affinity, P2-P3 peptidomimetic class of interleukin-1 beta-converting enzyme inhibitor.

  1997cited by this paper
• Human ICE/CED-3 protease nomenclature.

  1996cited by this paper
• Merck molecular force field. IV. conformational energies and geometries for MMFF94

  1996cited by this paper
• Merck molecular force field. V. Extension of MMFF94 using experimental data, additional computational data, and empirical rules

  1996cited by this paper
• Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94

  1996cited by this paper
• Merck molecular force field. III. Molecular geometries and vibrational frequencies for MMFF94

  1996cited by this paper
• Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions

  1996cited by this paper
• A Series of Well‐Defined Metathesis Catalysts–Synthesis of [RuCl2(CHR′)(PR3)2] and Its Reactions

  1995cited by this paper
• Structure and mechanism of interleukin-1 beta converting enzyme.

  1994cited by this paper
• Structure and mechanism of interleukin-lβ converting enzyme

  1994cited by this paper
• The role of interleukin-1 in disease.

  1993cited by this paper
• Seawater Sr isotope variation over the past 300 kyr and influence of global climate cycles

  1992cited by this paper
• Synthesis of a potent, reversible inhibitor of interleukin-1β converting enzyme

  1992cited by this paper
• A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes

  1992cited by this paper
• Semianalytical treatment of solvation for molecular mechanics and dynamics

  1990cited by this paper
• Identification of a monocyte specific pre-interleukin 1 beta convertase activity.

  1989cited by this paper
• A rapid approximation to the solvent accessible surface areas of atoms

  1988cited by this paper
• Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor.

  1988cited by this paper
• Effect of conformational change on reactivity in organic chemistry. Evaluations, applications, and extensions of Curtin-Hammett Winstein-Holness kinetics

  1983cited by this paper

• Interleukin-1β converting enzyme (ICE): A comprehensive review on discovery and development of caspase-1 inhibitors.

  2023cites this paper
• One‐Pot Preparation of Functionalized Azabicyclo[6.3.0]alkanone Amino Acids by Tandem Cross Enyne Metathesis/Ring‐Closing Metathesis

  2020cites this paper
• Chapter 2 Caspases – Key Players in Apoptosis

  2019cites this paper
• Rational Drug Design of Topically Administered Caspase 1 Inhibitors for the Treatment of Inflammatory Acne.

  2018cites this paper
• Rational approach to identify newer caspase-1 inhibitors using pharmacophore based virtual screening, docking and molecular dynamic simulation studies.

  2018cites this paper
• New Caspase-1 inhibitor by scaffold hopping into bio-inspired 3D-fragment space.

  2017cites this paper
• Anti-inflammatory Molecules: Immune System Mediators

  2017cites this paper
• Caspases – Key Players in Apoptosis

  2015cites this paper
• Synthesis of mevalonate- and fluorinated mevalonate prodrugs and their in vitro human plasma stability.

  2015cites this paper
• Small Molecule Active Site Directed Tools for Studying Human Caspases.

  2015cites this paper
• The chemistry of the carbon-transition metal double and triple bond : Annual survey covering the year 2006

  2009cites this paper
• Synthesis and evaluation of unsaturated caprolactams as interleukin-1beta converting enzyme (ICE) inhibitors.

  2007cites this paper